- Home
- KYMR vs EFSC Comparison
KYMR vs EFSC Comparison
Compare KYMR & EFSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- EFSC
- Stock Information
- Founded
- KYMR 2015
- EFSC 1988
- Country
- KYMR United States
- EFSC United States
- Employees
- KYMR N/A
- EFSC N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- EFSC Major Banks
- Sector
- KYMR Health Care
- EFSC Finance
- Exchange
- KYMR Nasdaq
- EFSC Nasdaq
- Market Cap
- KYMR 2.6B
- EFSC 2.1B
- IPO Year
- KYMR 2020
- EFSC 1999
- Fundamental
- Price
- KYMR $40.61
- EFSC $57.76
- Analyst Decision
- KYMR Buy
- EFSC Strong Buy
- Analyst Count
- KYMR 15
- EFSC 4
- Target Price
- KYMR $55.60
- EFSC $56.50
- AVG Volume (30 Days)
- KYMR 532.1K
- EFSC 155.3K
- Earning Date
- KYMR 02-20-2025
- EFSC 01-27-2025
- Dividend Yield
- KYMR N/A
- EFSC 1.94%
- EPS Growth
- KYMR N/A
- EFSC N/A
- EPS
- KYMR N/A
- EFSC 4.72
- Revenue
- KYMR $87,563,000.00
- EFSC $591,631,000.00
- Revenue This Year
- KYMR N/A
- EFSC N/A
- Revenue Next Year
- KYMR $33.16
- EFSC $0.15
- P/E Ratio
- KYMR N/A
- EFSC $12.24
- Revenue Growth
- KYMR 86.92
- EFSC N/A
- 52 Week Low
- KYMR $26.92
- EFSC $37.28
- 52 Week High
- KYMR $53.27
- EFSC $63.13
- Technical
- Relative Strength Index (RSI)
- KYMR 47.90
- EFSC 54.66
- Support Level
- KYMR $40.20
- EFSC $55.80
- Resistance Level
- KYMR $44.34
- EFSC $58.62
- Average True Range (ATR)
- KYMR 2.58
- EFSC 1.43
- MACD
- KYMR 0.29
- EFSC 0.25
- Stochastic Oscillator
- KYMR 57.47
- EFSC 83.68
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients.
About EFSC Enterprise Financial Services Corporation
Enterprise Financial Services Corporation is a financial holding company. It offers banking and wealth management services to individuals and business customers located in Arizona, California, Florida, Kansas, Missouri, Nevada, and New Mexico, in addition to loan and deposit production offices throughout the United States. The company offers a broad range of business and personal banking services including wealth management services. Lending services include commercial and industrial, commercial real estate, real estate construction and development, residential real estate, and consumer loans.